<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35584112</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1027</StartPage><EndPage>1038</EndPage><MedlinePgn>1027-1038</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51580</ELocationID><Abstract><AbstractText Label="BACKGROUND">Metabolic dysfunction has been suggested to be involved in the pathophysiology of amyotrophic lateral sclerosis (ALS). This study aimed to investigate the potential role of metabolic biomarkers in the progression of ALS and understand the possible metabolic mechanisms.</AbstractText><AbstractText Label="METHODS">Fifty-two patients with ALS and 24 normal controls were included, and blood samples were collected for analysis of metabolic biomarkers. Basal anthropometric measures, including body composition and clinical features, were measured in ALS patients. The disease progression rate was calculated using the revised ALS functional rating scale (ALSFRS-R) during the 6-month follow-up.</AbstractText><AbstractText Label="RESULTS">ALS patients had higher levels of adipokines (adiponectin, adipsin, resistin, and visfatin) and other metabolic biomarkers [C-peptide, glucagon, glucagon-like peptide 1 (GLP-1), gastric inhibitory peptide, and plasminogen activator inhibitor type 1] than controls. Leptin levels in serum were positively correlated with body mass index, body fat, and visceral fat index (VFI). Adiponectin was positively correlated with the VFI and showed a positive correlation with the ALSFRS-R and a negative correlation with baseline disease progression. Patients with lower body fat, VFI, and fat in limbs showed faster disease progression during follow-ups. Lower leptin and adiponectin levels were correlated with faster disease progression. After adjusting for confounders, lower adiponectin levels and higher visfatin levels were independently correlated with faster disease progression.</AbstractText><AbstractText Label="INTERPRETATION">The current study found altered levels of metabolic biomarkers in ALS patients, which may play a role in ALS pathogenesis. Adiponectin and visfatin represent potential biomarkers for prediction of disease progression in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Yue</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-7183-4430</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><Identifier Source="ORCID">0000-0002-5369-1541</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Chinese Academy of Medical Sciences, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiao-Han</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dong-Chao</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xun-Zhe</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ming-Sheng</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052242">Adiponectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020738">Leptin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.12</RegistryNumber><NameOfSubstance UI="D054409">Nicotinamide Phosphoribosyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D052242" MajorTopicYN="N">Adiponectin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054409" MajorTopicYN="N">Nicotinamide Phosphoribosyltransferase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35584112</ArticleId><ArticleId IdType="pmc">PMC9268864</ArticleId><ArticleId IdType="doi">10.1002/acn3.51580</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jesus P, Fayemendy P, Nicol M, et&#xa0;al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:97&#x2010;104. doi:10.1111/ene.13468</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides ZA, Ngo ST, Henderson RD, McCombe PA, Steyn FJ. Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression. Neurodegener Dis. 2016;16:382&#x2010;397. doi:10.1159/000446502</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446502</ArticleId><ArticleId IdType="pubmed">27400276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, et&#xa0;al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2010;1009. doi:10.1212/01.wnl.0000285080.70324.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Borges K. Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci. 2016;10:611. doi:10.3389/fnins.2016.00611</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallings NR, Puttaparthi K, Dowling KJ, et&#xa0;al. TDP&#x2010;43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS One. 2013;8:e71793. doi:10.1371/journal.pone.0071793</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071793</ArticleId><ArticleId IdType="pmc">PMC3742534</ArticleId><ArticleId IdType="pubmed">23967244</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Gordon PH, et&#xa0;al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166&#x2010;171. doi:10.3109/17482960902822960</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, O'Conner AG, Barrows JM, Shreiner DD, Birchak GJ, Zarnescu DC. Medium&#x2010;chain fatty acids, Beta&#x2010;hydroxybutyric acid and genetic modulation of the carnitine shuttle are protective in a drosophila model of ALS based on TDP&#x2010;43. Front Mol Neurosci. 2018;11:182. doi:10.3389/fnmol.2018.00182</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00182</ArticleId><ArticleId IdType="pmc">PMC5990617</ArticleId><ArticleId IdType="pubmed">29904341</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova PR, Esteras N, Abramov AY. Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention. Med Res Rev. 2021;41:770&#x2010;784. doi:10.1002/med.21712</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21712</ArticleId><ArticleId IdType="pubmed">32656815</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivan S, Martinez&#x2010;Beamonte R, Calvo AC, et&#xa0;al. Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. J Nutr Biochem. 2014;25:885&#x2010;892. doi:10.1016/j.jnutbio.2014.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2014.04.005</ArticleId><ArticleId IdType="pubmed">24917047</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, et&#xa0;al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high&#x2010;energy diet in a transgenic mouse model. Proc Natl Acad Sci USA. 2004;101:11159&#x2010;11164. doi:10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelstowska B, Baranczyk&#x2010;Kuzma A, Kuzma&#x2010;Kozakiewicz M. Dyslipidemia in patients with amyotrophic lateral sclerosis &#x2010; a case control retrospective study. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:195&#x2010;205. doi:10.1080/21678421.2020.1832119</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1832119</ArticleId><ArticleId IdType="pubmed">33103950</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R, Guo X, Chen X, et&#xa0;al. The serum lipid profiles of amyotrophic lateral sclerosis patients: a study from south&#x2010;West China and a meta&#x2010;analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:359&#x2010;365. doi:10.3109/21678421.2015.1047454</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1047454</ArticleId><ArticleId IdType="pubmed">26121273</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yazdani S, Piehl F, Magnusson PKE, Fang F. Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol Aging. 2018;67:202.e1&#x2010;202.e6. doi:10.1016/j.neurobiolaging.2018.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.022</ArticleId><ArticleId IdType="pubmed">29685649</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedic SI, Stevic Z, Dedic V, et&#xa0;al. Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis? Neurol Res. 2012;34:576&#x2010;580. doi:10.1179/1743132812Y.0000000049</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000049</ArticleId><ArticleId IdType="pubmed">22732100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiq MK, Lee E, Bradburn M, McDermott CJ, Shaw PJ. Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: insights from the olesoxime clinical trial. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:478&#x2010;484. doi:10.3109/21678421.2015.1062517</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1062517</ArticleId><ArticleId IdType="pubmed">26161993</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36:461&#x2010;470. doi:10.1016/j.tips.2015.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.04.014</ArticleId><ArticleId IdType="pubmed">26022934</ArticleId></ArticleIdList></Reference><Reference><Citation>Parimisetty A, Dorsemans AC, Awada R, Ravanan P, Diotel N, Lefebvre d&#x2019;Hellencourt C. Secret talk between adipose tissue and central nervous system via secreted factors&#x2010;an emerging frontier in the neurodegenerative research. J Neuroinflammation. 2016;13:67. doi:10.1186/s12974-016-0530-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0530-x</ArticleId><ArticleId IdType="pmc">PMC4806498</ArticleId><ArticleId IdType="pubmed">27012931</ArticleId></ArticleIdList></Reference><Reference><Citation>Procaccini C, Santopaolo M, Faicchia D, et&#xa0;al. Role of metabolism in neurodegenerative disorders. Metabolism. 2016;65:1376&#x2010;1390. doi:10.1016/j.metabol.2016.05.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2016.05.018</ArticleId><ArticleId IdType="pubmed">27506744</ArticleId></ArticleIdList></Reference><Reference><Citation>Letra L, Santana I. The influence of adipose tissue on brain development, cognition, and risk of neurodegenerative disorders. Adv Neurobiol. 2017;19:151&#x2010;161. doi:10.1007/978-3-319-63260-5_6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-63260-5_6</ArticleId><ArticleId IdType="pubmed">28933064</ArticleId></ArticleIdList></Reference><Reference><Citation>Forny&#x2010;Germano L, De Felice FG, Vieira M. The role of leptin and adiponectin in obesity&#x2010;associated cognitive decline and Alzheimer's disease. Front Neurosci. 2018;12:1027. doi:10.3389/fnins.2018.01027</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.01027</ArticleId><ArticleId IdType="pmc">PMC6340072</ArticleId><ArticleId IdType="pubmed">30692905</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron D . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2010;299. doi:10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MM, Thomas DR, Rubenstein LZ, et&#xa0;al. Appetite assessment: simple appetite questionnaire predicts weight loss in community&#x2010;dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82:1074&#x2010;1081. doi:10.1093/ajcn/82.5.1074</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/82.5.1074</ArticleId><ArticleId IdType="pubmed">16280441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Jiang H, Yang JX, et&#xa0;al. Body composition analysis by using bioelectrical impedance in a young healthy Chinese population: methodological considerations. Food Nutr Bull. 2017;38:172&#x2010;181. doi:10.1177/0379572117697534</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0379572117697534</ArticleId><ArticleId IdType="pubmed">28513264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansenova Manaskova S, van Belkum A, Endtz HP, et&#xa0;al. Comparison of non&#x2010;magnetic and magnetic beads in bead&#x2010;based assays. J Immunol Methods. 2016;436:29&#x2010;33. doi:10.1016/j.jim.2016.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2016.06.003</ArticleId><ArticleId IdType="pubmed">27296810</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham H, Chandler DJ, Dunbar SA. The genesis and evolution of bead&#x2010;based multiplexing. Methods. 2019;158:2&#x2010;11. doi:10.1016/j.ymeth.2019.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2019.01.007</ArticleId><ArticleId IdType="pubmed">30659874</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res. 2012;9:5&#x2010;17. doi:10.2174/156720512799015064</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720512799015064</ArticleId><ArticleId IdType="pmc">PMC4097094</ArticleId><ArticleId IdType="pubmed">22329649</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler C, Schweitzer L, Muller MJ. Functional correlates of detailed body composition in healthy elderly subjects. J Appl Physiol (1985). 2018;124:182&#x2010;189. doi:10.1152/japplphysiol.00162.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00162.2017</ArticleId><ArticleId IdType="pubmed">28751368</ArticleId></ArticleIdList></Reference><Reference><Citation>Park AJ, Battaglino RA, Nguyen NMH, Morse LR. Associations between lean mass and leptin in men with chronic spinal cord injury: results from the FRASCI&#x2010;muscle study. PLoS One. 2018;13:e0198969. doi:10.1371/journal.pone.0198969</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198969</ArticleId><ArticleId IdType="pmc">PMC6021064</ArticleId><ArticleId IdType="pubmed">29949600</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinggaard J, Hagen CP, Christensen AN, et&#xa0;al. Anthropometry, DXA, and leptin reflect subcutaneous but not visceral abdominal adipose tissue on MRI in 197 healthy adolescents. Pediatr Res. 2017;82:620&#x2010;628. doi:10.1038/pr.2017.138</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2017.138</ArticleId><ArticleId IdType="pubmed">28604756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape JA, Grose JH. The effects of diet and sex in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2020;176:301&#x2010;315. doi:10.1016/j.neurol.2019.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pmc">PMC8915943</ArticleId><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, D'Alvano G, Bonavita S, et&#xa0;al. Genetics and sex in the pathogenesis of amyotrophic lateral sclerosis (ALS): is there a link? Int J Mol Sci. 2020;21:10.3390/ijms21103647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279172</ArticleId><ArticleId IdType="pubmed">32455692</ArticleId></ArticleIdList></Reference><Reference><Citation>Giagulli VA, Castellana M, Pelusi C, et&#xa0;al. Androgens, body composition, and their metabolism based on sex. Front Horm Res. 2019;53:18&#x2010;32. doi:10.1159/000494900</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000494900</ArticleId><ArticleId IdType="pubmed">31499499</ArticleId></ArticleIdList></Reference><Reference><Citation>Perurena OH, Festoff BW. Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity. Neurology. 1987;37:1375&#x2010;1379. doi:10.1212/wnl.37.8.1375</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.37.8.1375</ArticleId><ArticleId IdType="pubmed">3614662</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald TS, Kumar V, Fung JN, Woodruff TM, Lee JD. Glucose clearance and uptake is increased in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis through an insulin&#x2010;independent mechanism. FASEB J. 2021;35:e21707. doi:10.1096/fj.202002450R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202002450R</ArticleId><ArticleId IdType="pubmed">34118098</ArticleId></ArticleIdList></Reference><Reference><Citation>Anoop S, Misra A, Bhatt SP, Gulati S, Mahajan H, Prabakaran G. High plasma glucagon levels correlate with waist&#x2010;to&#x2010;hip ratio, suprailiac skinfold thickness, and deep subcutaneous abdominal and intraperitoneal adipose tissue depots in nonobese Asian Indian males with type 2 diabetes in North India. J Diabetes Res. 2017;2017:2376016. doi:10.1155/2017/2376016</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2376016</ArticleId><ArticleId IdType="pmc">PMC5467315</ArticleId><ArticleId IdType="pubmed">28634585</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas E, Ahmed Siddiqui I, Khan MS, Perveen K, Butt A, Fawwad A. Fasting glucagon level in type 2 diabetes and impaired glucose tolerance and its association with diabetes&#x2010;associated clinical parameters: a study from Karachi, Pakistan. Cureus. 2021;13:e13430. doi:10.7759/cureus.13430</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13430</ArticleId><ArticleId IdType="pmc">PMC7978393</ArticleId><ArticleId IdType="pubmed">33758717</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Treleaven CM, Fidler JA, et&#xa0;al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci USA. 2013;110:10812&#x2010;10817. doi:10.1073/pnas.1308421110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Li R, Kirk SE, et&#xa0;al. Altered skeletal muscle glucose&#x2010;fatty acid flux in amyotrophic lateral sclerosis. Brain Commun. 2020;2:fcaa154. doi:10.1093/braincomms/fcaa154</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa154</ArticleId><ArticleId IdType="pmc">PMC7677608</ArticleId><ArticleId IdType="pubmed">33241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Phan K, Highton&#x2010;Williamson E, et&#xa0;al. Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Ann Clin Transl Neurol. 2019;6:486&#x2010;495. doi:10.1002/acn3.721</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.721</ArticleId><ArticleId IdType="pmc">PMC6414477</ArticleId><ArticleId IdType="pubmed">30911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Peter RS, Rosenbohm A, et&#xa0;al. Adipokines, C&#x2010;reactive protein and amyotrophic lateral sclerosis &#x2010; results from a population&#x2010; based ALS registry in Germany. Sci Rep. 2017;7:4374. doi:10.1038/s41598-017-04706-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04706-5</ArticleId><ArticleId IdType="pmc">PMC5491500</ArticleId><ArticleId IdType="pubmed">28663573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer&#x2010;Donato A, Contreras A, Frago LM, et&#xa0;al. Alterations in leptin signaling in amyotrophic lateral sclerosis (ALS). Int J Mol Sci. 2021;22:10.3390/ijms221910305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508891</ArticleId><ArticleId IdType="pubmed">34638645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunma S, Ramuth H, Miles&#x2010;Chan JL, et&#xa0;al. Do gender and ethnic differences in fasting leptin in Indians and Creoles of Mauritius persist beyond differences in adiposity? Int J Obes (Lond). 2018;42:280&#x2010;283. doi:10.1038/ijo.2017.213</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2017.213</ArticleId><ArticleId IdType="pubmed">28852206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Zhong L, Zhu C, et&#xa0;al. Role of leptin in mood disorder and neurodegenerative disease. Front Neurosci. 2019;13:378. doi:10.3389/fnins.2019.00378</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00378</ArticleId><ArticleId IdType="pmc">PMC6510114</ArticleId><ArticleId IdType="pubmed">31130833</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, et&#xa0;al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population&#x2010;based cohort. J Neurol Neurosurg Psychiatry. 2019;90:666&#x2010;673. doi:10.1136/jnnp-2018-319611</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Murthy SB, Wilson AM, et&#xa0;al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010;11:542&#x2010;548. doi:10.3109/17482968.2010.482592</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.482592</ArticleId><ArticleId IdType="pubmed">20500116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64:131&#x2010;145. doi:10.1016/j.metabol.2014.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2014.10.016</ArticleId><ArticleId IdType="pubmed">25497344</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51&#x2010;58. doi:10.1016/j.cyto.2016.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2016.10.011</ArticleId><ArticleId IdType="pmc">PMC5453851</ArticleId><ArticleId IdType="pubmed">27916613</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman A, Hernandez&#x2010;Coronado CG, Rosales&#x2010;Torres AM, et&#xa0;al. Leptin regulates neuropeptides associated with food intake and GnRH secretion. Ann Endocrinol (Paris). 2019;80:38&#x2010;46. doi:10.1016/j.ando.2018.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ando.2018.07.012</ArticleId><ArticleId IdType="pubmed">30243474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MA, Bence KK, Sandesara I, et&#xa0;al. Genetically altering organismal metabolism by leptin&#x2010;deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23:4995&#x2010;5008. doi:10.1093/hmg/ddu214</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu214</ArticleId><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Peters&#xe9;n &#xc5;. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2021;47:979&#x2010;989. doi:10.1111/nan.12709</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12709</ArticleId><ArticleId IdType="pubmed">33755993</ArticleId></ArticleIdList></Reference><Reference><Citation>Alti D, Sambamurthy C, Kalangi SK. Emergence of leptin in infection and immunity: scope and challenges in vaccines formulation. Front Cell Infect Microbiol. 2018;8:147. doi:10.3389/fcimb.2018.00147</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00147</ArticleId><ArticleId IdType="pmc">PMC5954041</ArticleId><ArticleId IdType="pubmed">29868503</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Simpson EP, Appel SH. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol. 2018;31:635&#x2010;639. doi:10.1097/WCO.0000000000000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, Steyn FJ, Huang L, et&#xa0;al. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2015;357:22&#x2010;27. doi:10.1016/j.jns.2015.06.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H, Judd RL. Adiponectin regulation and function. Compr Physiol. 2018;8:1031&#x2010;1063. doi:10.1002/cphy.c170046</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c170046</ArticleId><ArticleId IdType="pubmed">29978896</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80&#x2010;84. doi:10.1016/j.cca.2012.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2012.12.007</ArticleId><ArticleId IdType="pubmed">23266767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784&#x2010;1792. doi:10.1172/JCI29126</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29126</ArticleId><ArticleId IdType="pmc">PMC1483172</ArticleId><ArticleId IdType="pubmed">16823476</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sweeney G. Adiponectin action in skeletal muscle. Best Pract Res Clin Endocrinol Metab. 2014;28:33&#x2010;41. doi:10.1016/j.beem.2013.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2013.08.003</ArticleId><ArticleId IdType="pubmed">24417944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari R, Kumar S, Kant R. An update on metabolic syndrome: metabolic risk markers and adipokines in the development of metabolic syndrome. Diabetes Metab Syndr. 2019;13:2409&#x2010;2417. doi:10.1016/j.dsx.2019.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2019.06.005</ArticleId><ArticleId IdType="pubmed">31405652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuhara A, Matsuda M, Nishizawa M, et&#xa0;al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426&#x2010;430. doi:10.1126/science.1097243</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1097243</ArticleId><ArticleId IdType="pubmed">15604363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E, Dupuis L, Muller HP, et&#xa0;al. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One. 2013;8:e67783. doi:10.1371/journal.pone.0067783</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Berndt J, Kloting N, Kralisch S, et&#xa0;al. Plasma visfatin concentrations and fat depot&#x2010;specific mRNA expression in humans. Diabetes. 2005;54:2911&#x2010;2916. doi:10.2337/diabetes.54.10.2911</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.54.10.2911</ArticleId><ArticleId IdType="pubmed">16186392</ArticleId></ArticleIdList></Reference><Reference><Citation>Willers SM, Brunekreef B, Abrahamse&#x2010;Berkeveld M, et&#xa0;al. Serum visfatin and leptin in relation to childhood adiposity and body fat distribution: the PIAMA birth cohort study. Ann Nutr Metab. 2015;66:63&#x2010;71. doi:10.1159/000369979</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369979</ArticleId><ArticleId IdType="pubmed">25612646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitticharoon C, Nway NC, Chatree S, Churintaraphan M, Boonpuan P, Maikaew P. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Peptides. 2014;62:164&#x2010;175. doi:10.1016/j.peptides.2014.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2014.10.006</ArticleId><ArticleId IdType="pubmed">25453978</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl TB, Holm S, Aukrust P, Halvorsen B. Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu Rev Nutr. 2012;32:229&#x2010;243. doi:10.1146/annurev-nutr-071811-150746</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-071811-150746</ArticleId><ArticleId IdType="pubmed">22462624</ArticleId></ArticleIdList></Reference><Reference><Citation>Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul. 2010;44:25&#x2010;36. doi:10.4149/endo_2010_01_25</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/endo_2010_01_25</ArticleId><ArticleId IdType="pubmed">20151765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>